January 22, 2025
RegMed Investors’ (RMi) pre-open: pre-emptive pardon your portfolio
January 21, 2025
RegMed Investors’ (RMi) pre-open: Post Inauguration, a new barometer
January 15, 2025
RegMed Investors’ (RMi) pre-open: more economics
January 14, 2025
RegMed Investors’ (RMi) pre-open: get it up, futures are higher
January 13, 2025
RegMed Investors’ (RMi) pre-open: Rollover Breathe, gotta see something today
January 10, 2025
RegMed Investors’ (RMi) pre-open: snap, crackle or a pop?
January 8, 2025
RegMed Investors’ (RMi) pre-open: calibrate
January 7, 2025
RegMed Investors’ (RMi) pre-open: expectation versus reality
January 6, 2025
RegMed Investors’ (RMi) pre-open: tools of 2025, headwinds and operation budgets
January 2, 2025
RegMed Investors’ (RMi) pre-open: the beginning of a long list of expectations
December 31, 2024
RegMed Investors’ (RMi) pre-open: about to lift momentum in final session, for week, of month and year end
December 30, 2024
RegMed Investors’ (RMi) pre-open: There’s always risk with 2 sessions left until 2024’s end
December 27, 2024
RegMed Investors’ (RMi) pre-open: short week, even shorter fuse with downbeat open numbers
December 23, 2024
Merry Christmas and Happy Holiday to All
December 20, 2024
RegMed Investors’ (RMi) pre-open: WTF
December 17, 2024
RegMed Investors’ (RMi) pre-open: who is on 1st, what’s on 2nd and cell and gene therapies are on 3rd?
December 13, 2024
RegMed Investors’ (RMi) pre-open: blood awash in the cell and gene therapy sector
December 12, 2024
RegMed Investors’ (RMi) pre-open: the hits keep a’comin’
December 11, 2024
RegMed Investors’ (RMi) pre-open: more econs
December 10, 2024
RegMed Investors’ (RMi) pre-open: everything’s relevant
December 9, 2024
RegMed Investors’ (RMi) pre-open: momentum mania creates a soon to be a cratering sector
December 6, 2024
RegMed Investors’ (RMi) pre-open: risk-on or off exposure?
December 5, 2024
RegMed Investors’ (RMi) pre-open: caution
December 4, 2024
RegMed Investors’ (RMi) pre-open: expectation versus consequences
December 2, 2024
RegMed Investors’ (RMi) pre-open: room to run or show their bum?
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors
© 2025 RegMed Investors (regmedinvestors.com), all rights are reserved.
RegMed Investors (RMi) or Regmedinvestors.com content is the intellectual property of Henry McCusker. Any copying, republication or redistribution of RMI’s content, including by framing or similar means, is expressly prohibited without the prior written consent of Scimitar; who also shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. For additional information on other Scimitar media services or reposting please email hwm@regmedinvestors.com.
The information included above as well as individual companies and/or securities mentioned should be construed as guidance in RMi reviews.
The facts stated and the opinions given in this publication are based on data and information considered to be reliable and have been carefully worked into my qualitative analyses and prognoses. However, no guarantee can be given as to their fairness, accuracy or completeness.
Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.